Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Randomized Controlled 8-Week Crossover Evaluation of Compression Bandage Systems for Venous Leg Ulcers

This study has been completed.
Information provided by:
3M Identifier:
First received: March 10, 2006
Last updated: October 10, 2007
Last verified: October 2007
The purpose of this study is to evaluate the product performance of a new 2-layer compression bandage for the treatment of venous leg ulcers.

Condition Intervention
Venous Ulcer
Device: Coban 2 Layer Compression System

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Randomized Controlled Eight Week Cross-Over Clinical Evaluation of the 3M Coban 2-Layer Compression System to Evaluate the Product Performance in Patients With Venous Leg Ulcers

Resource links provided by NLM:

Further study details as provided by 3M:

Primary Outcome Measures:
  • Product Performance

Estimated Enrollment: 80
Study Start Date: March 2006
Study Completion Date: April 2007
Detailed Description:
The purpose of this study is to evaluate the product performance of a new 2-layer compression bandage for the treatment of venous leg ulcers. The new bandage is a 2-layer compression system. It will be used over primary dressings to provide the compression that is beneficial to venous leg ulcers.

Ages Eligible for Study:   21 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • venous leg ulcer
  • patient can walk

Exclusion Criteria:

  • cancerous ulcers
  • diabetic foot ulcer
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00301496

United States, Alabama
Institute for Advanced Wound Care
Montgomery, Alabama, United States, 36111
United States, California
Center for Clinical Research, Inc.
Castro Valley, California, United States, 94546
United States, Georgia
Gwinnet Hospital System
Lawrenceville, Georgia, United States, 30045
United States, Illinois
Wound Healing and Treatment Center - Silver Cross Hospital
Joliet, Illinois, United States, 60432
United States, Indiana
Wound Healing Center
Terre Haute, Indiana, United States, 47807
Canada, Quebec
Dermatology Clinic - Montreal General Hospital
Montreal, Quebec, Canada, H3G 1A4
Dermatology Clinic
Mississauga, Ontario, Canada, L4Y 1A6
United Kingdom
Wound Healing Research Unit
Cardiff, United Kingdom
Grantham & District Hospital
Grantham, United Kingdom
Clayponds Hospital
London, United Kingdom
Sponsors and Collaborators
Principal Investigator: Christine Moffatt, PhD, MA, RGN Centre for Research and Implementation of Clinical Practice
  More Information Identifier: NCT00301496     History of Changes
Other Study ID Numbers: 05-010302
Study First Received: March 10, 2006
Last Updated: October 10, 2007

Additional relevant MeSH terms:
Varicose Ulcer
Leg Ulcer
Pathologic Processes
Varicose Veins
Vascular Diseases
Cardiovascular Diseases
Skin Ulcer
Skin Diseases processed this record on May 25, 2017